Stan Mikulowski
Directeur Général chez SACS Medical AB
Profil
Stan Mikulowski is currently the Chief Executive Officer at SACS Medical AB and OrtoWay AB.
He previously held the position of Chief Executive Officer at Biovator AB.
He was also the Chief Executive Officer at Recopharma AB from 2008 to 2009.
In addition, he worked as the Senior Venture Manager at CareDx International (Private Equity) from 2004 to 2010 and as the VP & Vice President Senior Venture Manager at CareDx International AB in 2010.
Postes actifs de Stan Mikulowski
| Sociétés | Poste | Début |
|---|---|---|
SACS Medical AB
 SACS Medical AB Information Technology ServicesTechnology Services SACS Medical AB provides information technology solutions for signal handling in health care and medical research. Its products include the SACS Concept, SACS EEG workstation and SACS Video EEG workstation. The company is headquartered in Askim, Sweden | Directeur Général | - |
OrtoWay AB
 OrtoWay AB Medical SpecialtiesHealth Technology OrtoWay AB develops instruments for spinal surgery. It facilitates the deployment of artificial discs. The company was founded in October 2006 and is headquartered in Danderyd, Sweden. | Directeur Général | - |
Anciens postes connus de Stan Mikulowski
| Sociétés | Poste | Fin |
|---|---|---|
Biovator AB
 Biovator AB Miscellaneous Commercial ServicesCommercial Services Biovator AB develops innovative, unique in vitro tests (i.e. in test tubes) which predict the risk for allergic sensitization. Many products, such as pharmaceuticals, cosmetics and food additives may be allergens, causing allergic reactions. For this reason they are tested for allergen city. Up to now such tests have been performed in laboratory animals. Biovator AB is developing two in vitro tests: the Cytokine Profile Assay (CPA) and the Gene Activation Profile Assay (GAPA). CPA will be the first allergen city test of any type, which can predict hypersensitivity reactions of the so called Type I. The Biovator technologies are well in line with EU legislative initiatives such as banning animal testing of cosmetics 2009. | President | 13/03/2012 |
CareDx International (Private Equity)
 CareDx International (Private Equity) Investment ManagersFinance Allenex (Private Equity) (Allnex PE) is the private equity division of LinkMed AB (ST: LMED) in Sweden. Located in Stockholm, the firm was formerly known as LinkMed Private Equity, founded by Ingemar Lagerlöf in 1998. To assure the continued growth of their investee companies, Allnex PE has assembled a network of medical and managerial resources, divided into Corporate Operational Functions (Board and Management Team) and the Venture Management Network (Business Network and Scientific Advisory Board). The Venture Management Network provides guidance and strategic expertise to investee companies. | Private Equity Investor | 31/10/2010 |
| ALLENEX AB | Corporate Officer/Principal | - |
Recopharma AB
 Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | President | 25/11/2009 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
SACS Medical AB
SACS Medical AB Information Technology ServicesTechnology Services SACS Medical AB provides information technology solutions for signal handling in health care and medical research. Its products include the SACS Concept, SACS EEG workstation and SACS Video EEG workstation. The company is headquartered in Askim, Sweden | Technology Services |
CareDx International (Private Equity)
CareDx International (Private Equity) Investment ManagersFinance Allenex (Private Equity) (Allnex PE) is the private equity division of LinkMed AB (ST: LMED) in Sweden. Located in Stockholm, the firm was formerly known as LinkMed Private Equity, founded by Ingemar Lagerlöf in 1998. To assure the continued growth of their investee companies, Allnex PE has assembled a network of medical and managerial resources, divided into Corporate Operational Functions (Board and Management Team) and the Venture Management Network (Business Network and Scientific Advisory Board). The Venture Management Network provides guidance and strategic expertise to investee companies. | Finance |
Biovator AB
Biovator AB Miscellaneous Commercial ServicesCommercial Services Biovator AB develops innovative, unique in vitro tests (i.e. in test tubes) which predict the risk for allergic sensitization. Many products, such as pharmaceuticals, cosmetics and food additives may be allergens, causing allergic reactions. For this reason they are tested for allergen city. Up to now such tests have been performed in laboratory animals. Biovator AB is developing two in vitro tests: the Cytokine Profile Assay (CPA) and the Gene Activation Profile Assay (GAPA). CPA will be the first allergen city test of any type, which can predict hypersensitivity reactions of the so called Type I. The Biovator technologies are well in line with EU legislative initiatives such as banning animal testing of cosmetics 2009. | Commercial Services |
Recopharma AB
Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Health Technology |
OrtoWay AB
OrtoWay AB Medical SpecialtiesHealth Technology OrtoWay AB develops instruments for spinal surgery. It facilitates the deployment of artificial discs. The company was founded in October 2006 and is headquartered in Danderyd, Sweden. | Health Technology |
CareDx International AB
 CareDx International AB BiotechnologyHealth Technology CareDx International AB engages in the development, manufacture, and sale of products for transplantation of blood stem cells and organs. It offers tissue typing products and products for antibody detection. The company was founded by Ingemar Lagerlöf in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
